NRSN — NeuroSense Therapeutics Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1875091 ·
Last close
$1.51
Market Cap
$2.86M
52W High
$25.40
52W Low
$1.10
ADV30
38,629
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 896,000 231,000 2,999,000
Dec 2025 — — — — 1,028,000 166,000 2,588,000
Jun 2025 — — — — 1,684,000 666,000 2,203,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-51,348,000
Inventory
—
Receivables
$540,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
2

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -11,085,000 -11,125,000 1,028,000 2,588,000 -1,560,000 -7,671,000
Dec 2024 0 -9,902,000 -10,210,000 4,575,000 1,992,000 2,583,000 -10,135,000
Dec 2023 0 -12,049,000 -10,107,000 3,185,000 4,944,000 -1,759,000 -8,354,000
Dec 2022 0 -10,554,000 -10,492,000 7,710,000 2,091,000 5,619,000 -7,616,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-13.50

Peers — same industry

TickerNameMarket CapLastDaily %
GELS Gelteq Ltd $2.88M $0.27 —
MDCX Medicus Pharma Ltd. $2.89M $1.52 —
DRMA Dermata Therapeutics, Inc. $2.81M $0.57 —
APUS Apimeds Pharmaceuticals US, Inc. $2.94M $1.95 —
PPBT PURPLE BIOTECH LTD. $2.78M $1.71 —

News headlines (Yahoo Finance, 1h cache)

NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data
2026-11-02 14:00 · Yahoo
NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026
2026-10-29 15:30 · Yahoo
NeuroSense Files U.S. Patent Application for Traumatic Brain Injury
2026-10-19 12:25 · Yahoo
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
2026-10-13 12:30 · Yahoo
NeuroSense Provides Update on Nasdaq Listing Compliance
2026-10-02 20:15 · Yahoo
NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
2026-09-28 16:43 · Yahoo
NeuroSense Provides Business Update and Progress for the First Half of 2026
2026-09-25 20:30 · Yahoo
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
2026-09-10 13:00 · Yahoo
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
2026-08-31 12:45 · Yahoo
NeuroSense Issues CEO Letter to Shareholders
2026-08-13 13:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.